ArticleBriefings in bioinformatics2025
scHDeepInsight: a hierarchical deep learning framework for precise immune cell annotation in single-cell RNA-seq data.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- scHilda: Hierarchical Integration of LLM with KG database for single cell type annotation.PLoS computational biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurate classification of immune cells is crucial for elucidating their diverse roles in health and disease. However, this task remains very challenging in single-cell RNA sequencing (scRNA-seq) data due to the complex and hierarchical relationships of immune cell types. To address this, we introduce scHDeepInsight, a deep learning framework that extends our previous scDeepInsight model by integrating a biologically-informed classification architecture with an adaptive hierarchical focal loss (AHFL). The framework builds on our established method of converting gene expression data into two-dimensional structured images, enabling convolutional neural networks to effectively capture both global and fine-grained transcriptomic features. This design utilizes hierarchical relationships among immune cell types to enhance the classification ability beyond the flat classification approaches. scHDeepInsight dynamically adjusts loss contributions to balance performance across the hierarchy levels. Comprehensive benchmarking across seven diverse tissue datasets shows scHDeepInsight achieves an average accuracy of 93.2%, surpassing contemporary methods by 5.1 percentage points. The model successfully distinguishes 50 distinct immune cell subtypes with high accuracy, demonstrating proficiency for identifying rare and closely related cell subtypes. Additionally, SHAP-based interpretability quantifies individual gene contributions to reveal the biological basis of classification decisions. These qualities make scHDeepInsight a robust tool for high-resolution cell subtype characterization, well-suited for detailed profiling in immunological studies and extensible to nonimmune cell types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.